Aerovate Therapeutics Inc... (AVTE)

AI Score

Unlock

2.75

0.01 (0.36%)

At close: Apr 24, 2025, 3:59 PM

2.67

-2.73%

After-hours: Apr 24, 2025, 05:26 PM EDT

Aerovate Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	33.75M	31.11M	31.07M	9.12M	23.49M	32.18M	60.9M	26.57M	22.4M	22.42M	27.46M	28.14M	54.2M	180.88M	59.15M	8.64M	4.57M	-3.51M
Short-Term Investments	44.87M	57.62M	73.13M	90.21M	98.95M	103.02M	89.19M	92.36M	106.82M	120.16M	124.53M	132.94M	113.18M	n/a	n/a	n/a	n/a	7.03M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	81K	81K	2.6M	2.28M	2.24M	2.23M	2.65M	2.56M	1.08M	731K	327K	302K	278K	3.09M	307K	n/a	-3.51M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	845K	882K	452K	304K	250K	567K	n/a	266K	295K	331K	226K	289K	240K	2.22M	159K	n/a	38K	n/a
Total Current Assets	80.12M	90.61M	110.76M	103.24M	124.23M	137.6M	152.47M	120.57M	131.5M	145.16M	153.45M	165.88M	174.33M	183.1M	59.31M	9.6M	4.68M	3.51M
Property-Plant & Equipment	215K	273K	853K	985K	902K	1.03M	1.06M	1.18M	1.25M	1.42M	1.5M	787K	728K	745K	35K	37K	39K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	215K	354K	934K	3.58M	3.19M	3.27M	3.29M	3.82M	3.81M	2.5M	2.23M	1.11M	1.03M	1.02M	3.13M	344K	39K	-3.51M
Total Assets	80.33M	90.96M	111.69M	106.82M	127.42M	140.88M	155.75M	124.39M	135.3M	147.66M	155.68M	167M	175.36M	184.13M	62.43M	9.95M	4.71M	n/a
Account Payables	224K	908K	4.18M	3.31M	2.4M	3.5M	5.53M	4.73M	2.58M	4.54M	2.07M	2.86M	1.21M	2.55M	3.03M	1.54M	612K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	10.33M	6.79M	n/a	n/a	n/a	n/a	n/a	1.01M	943K	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	475K	n/a	420K	451K	379K	n/a	n/a	379K	347K	193K	192K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	319K	292K	9.23M	10.43M	10.03M	-12K	204K	252K	3.13M	1.26M	177K	1.07M	168K	180K	417K	145K	24K	n/a
Total Current Liabilities	3.83M	10.31M	17.02M	15.52M	17.64M	14.72M	13.28M	10.64M	7.78M	7.71M	3.76M	4.7M	2.55M	3.83M	4.19M	1.78M	1.77M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	70K	70K	70K	70K	70K	70K	69K	70K	71K	13K	862K	335K	13K	n/a	n/a	24.28M	16.29M	n/a
Total Long-Term Liabilities	70K	151K	276K	399K	325K	428K	545K	661K	776K	813K	875K	349K	395K	452K	79.82M	24.28M	16.29M	n/a
Total Liabilities	3.9M	10.47M	17.3M	15.92M	17.96M	15.15M	13.83M	11.3M	8.56M	8.52M	4.63M	5.05M	2.94M	4.28M	84.01M	26.06M	18.06M	n/a
Total Debt	417K	540K	681K	774K	675K	809K	855K	964K	1.09M	1.18M	1.21M	528K	574K	599K	n/a	n/a	n/a	n/a
Common Stock	3K	3K	3K	3K	3K	3K	3K	2K	2K	2K	2K	2K	2K	2K	n/a	n/a	n/a	n/a
Retained Earnings	-233.05M	-227.62M	-211.38M	-186.61M	-163.42M	-143.01M	-123.45M	-104.42M	-87.9M	-72.88M	-59.29M	-47.3M	-36.39M	-28.17M	-21.98M	-16.2M	-13.41M	n/a
Comprehensive Income	105K	n/a	-83K	-33K	237K	-195K	-223K	-201K	-466K	-771K	-785K	-644K	-59K	-184.13M	n/a	0.00	n/a	-3.64M
Shareholders Equity	76.43M	80.49M	94.4M	90.9M	109.46M	125.72M	141.93M	113.09M	126.74M	139.14M	151.05M	161.95M	172.42M	179.85M	-21.58M	-16.11M	-13.34M	357K
Total Investments	44.87M	57.62M	73.13M	90.21M	98.95M	103.02M	89.19M	92.36M	106.82M	120.16M	124.53M	132.94M	113.18M	n/a	n/a	n/a	n/a	7.03M